medigraphic.com
ISSN 2500-7106 (Digital)
ISSN 0123-2576 (Impreso)
Medicina & Laboratorio

2014, Número 11-12

<< Anterior Siguiente >>

Medicina & Laboratorio 2014; 20 (11-12)


Síndrome de plaqueta pegajosa

Campuzano-Maya G, Escobar-Gallo GE

Idioma: Español
Referencias bibliográficas: 99
Paginas: 513-528
Archivo PDF: 664.82 Kb.


RESUMEN

El síndrome de plaqueta pegajosa es una trombofilia hereditaria, de carácter autosómico dominante, caracterizada por aumento in vitro de la agregación plaquetaria en respuesta a bajas concentraciones de epinefrina y/o adenosindifosfato (ADP) que se expresa como un estado protrombótico, tanto arterial como venoso. De acuerdo con el patrón de la agregometría plaquetaria con diferentes concentraciones de epinefrina y ADP, se presentan tres formas: síndrome de plaqueta pegajosa tipo I, hiperagregación plaquetaria con epinefrina y ADP; síndrome de plaqueta pegajosa tipo II, hiperagregación plaquetaria con epinefrina sola; y, síndrome de plaqueta pegajosa tipo III, hiperagregación plaquetaria con ADP solo. Las manifestaciones clínicas están relacionadas con la predisposición a trombosis arteriales o venosas, que se expresan como isquemia coronaria o cerebral, isquemia de vasos retinianos y trastornos de la microcirculación placentaria que puede asociarse con restricción del crecimiento intrauterino del feto, preeclampsia, eclampsia y pérdidas fetales, entre otras manifestaciones. El diagnóstico del síndrome de plaqueta pegajosa se establece mediante la agregación plaquetaria al demostrar la hiperagregación de las plaquetas inducida por pequeñas dosis de epinefrina y/o ADP. El tratamiento se basa en la administración de antiagregantes plaquetarios, siendo la aspirina a baja dosis la droga ideal y el clopidogrel cuando hay resistencia a la aspirina o esta está contraindicada. El objetivo de este módulo es revisar la literatura médica mundial sobre este nuevo síndrome que debe ser tenido en cuenta en el diagnóstico y manejo de la trombofilia como una nueva opción para el paciente afectado por uno de estos síntomas.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Cohoon KP, Heit JA. Inherited and secondary thrombophilia. Circulation 2014; 129: 254-257.

  2. Holiday PL, Mammen E, Gilroy J. Sticky platelet syndrome and cerebral infarction in young adults. Paper Presented at: The Ninth International Joint Conference on Stroke and Cerebral Circulation; 1983 (abstract). Phoenix, Arizona, Estados Unidos.

  3. Kubisz P, Stasko J, Holly P. Sticky platelet syndrome. Semin Thromb Hemost 2013; 39: 674-683.

  4. Guevara-Arismendy NM, Escobar-Gallo GE, Campuzano-Maya G. Utilidad clínica de la agregregometría plaquetaria. Medicina & Laboratorio 2012; 18: 311-332.

  5. al-Mefty O, Marano G, Raiaraman S, Nugent GR, Rodman N. Transient ischemic attacks due to increased platelet aggregation and adhesiveness. Ultrastructural and functional correlation. J Neurosurg 1979; 50: 449-453.

  6. Rubenfire M, Blevins RD, Barnhart M, Housholder S, Selik N, Mammen EF. Platelet hyperaggregability in patients with chest pain and angiographically normal coronary arteries. Am J Cardiol 1986; 57: 657-660.

  7. Mammen EF. Ten years experience with the sticky platelet syndrome. Clin Appl Thromb Hemost 1995; 1: 66-72.

  8. Bick RL. Sticky platelet syndrome: A common cause of unexplained arterial and venous thrombosis. Clin Appl Thromb Hemost 1998; 4: 77-81.

  9. Alonso A, Soto I, Urgelles MF, Corte JR, Rodriguez MJ, Pinto CR. Acquired and inherited thrombophilia in women with unexplained fetal losses. Am J Obstet Gynecol 2002; 187: 1337-1342.

  10. Sokol J, Biringer K, Skerenova M, Hasko M, Bartosova L, Stasko J, et al. Platelet aggregation abnormalities in patients with fetal losses: the GP6 gene polymorphism. Fertil Steril 2012; 98: 1170-1174.

  11. Mammen EF, Barnhart MI, Selik NR, Gilroy J, Klepach GL. “Sticky platelet syndrome”: a congenital platelet abnormality predisposing to thrombosis? Folia Haematol Int Mag Klin Morphol Blutforsch 1988; 115: 361-365.

  12. Berg-Dammer E, Henkes H, Trobisch H, Kuhne D. Sticky platelet syndrome: a cause of neurovascular thrombosis and thrombo-embolism. Interv Neuroradiol 1997; 3: 145-154.

  13. Chittoor SR, Elsehety AE, Roberts GF, Laughlin WR. Sticky platelet syndrome: a case report and review of the literature. Clin Appl Thromb Hemost 1998; 4: 280-284.

  14. Chaturvedi S, Dzieczkowski JS. Protein S deficiency, activated protein C resistance and sticky platelet syndrome in a young woman with bilateral strokes. Cerebrovasc Dis 1999; 9: 127-130.

  15. Mammen EF. Sticky platelet syndrome. Semin Thromb Hemost 1999; 25: 361-365.

  16. Ruíz-Argüelles GJ, López-Martínez B, Cruz- Cruz D, Esparza-Silva L, Reyes-Aulis MB. Primary thrombophilia in México III: A prospective study of the sticky platelet syndrome. Clin Appl Thromb Hemost 2002; 8: 273-277.

  17. Frenkel EP, Mammen EF. Sticky platelet syndrome and thrombocythemia. Hematol Oncol Clin North Am 2003; 17: 63-83.

  18. Lewerenz V, Burchardt T, Buchau A, Ruzicka T, Megahed M. [Livedoid vasculopathy with heterozygous factor V Leiden mutation and sticky platelet syndrome]. Hautarzt 2004; 55: 379-381.

  19. Andersen J. Sticky platelet syndrome. Clin Adv Hematol Oncol 2006; 4: 432-434.

  20. Kubisz P, Ivankov J, Holly P, Stasko JN, Musial J. The glycoprotein IIIa PL(A1/A2) polymorphism--a defect responsible for the sticky platelet syndrome? Clin Appl Thromb Hemost 2006; 12: 117-119.

  21. Muhlfeld AS, Ketteler M, Schwamborn K, Eitner F, Schneider B, Gladziwa U, et al. Sticky platelet syndrome: an underrecognized cause of graft dysfunction and thromboembolic complications in renal transplant recipients. Am J Transplant 2007; 7: 1865-1868.

  22. Randhawa S, Van Stavern GP. Sticky platelet syndrome and anterior ischaemic optic neuropathy. Clin Experiment Ophthalmol 2007; 35: 779-781.

  23. El-Amm JM, Andersen J, Gruber SA. Sticky platelet syndrome: a manageable risk factor for posttransplant thromboembolic events. Am J Transplant 2008; 8: 465.

  24. Kannan S, Dhanasegaran S, Raji V. Recurrent arterial thrombosis in a young male: sticky platelet syndrome. Internet J Hematol 2008; 4.

  25. Mears KA, Van Stavern GP. Bilateral simultaneous anterior ischaemic optic neuropathy associated with Sticky Platelet Syndrome. Br J Ophthalmol 2009; 93: 885-886, 913.

  26. Sand M, Mann B, Bechara FG, Sand D. Sticky platelet syndrome type II presenting with arterial microemboli in the fingers. Thromb Res 2009; 124: 244.

  27. Bojalian MO, Akingba AG, Andersen JC, Swerdlow PS, Bove PG, Brown OW, et al. Sticky platelet syndrome: an unusual presentation of arterial ischemia. Ann Vasc Surg 2010; 24: 691 e691-696.

  28. Kubisz P, Bartosova L, Ivankova J, Holly P, Stasko J, Skerenova M, et al. Is Gas6 protein associated with sticky platelet syndrome? Clin Appl Thromb Hemost 2010; 16: 701-704.

  29. Loeffelbein DJ, Baumann CM, Mucke T, Wolff KD, Holzle F, Kesting MR. Sticky platelet syndrome as a possible cause for free flap failure--a case report. Microsurgery 2010; 30: 466-468.

  30. Gehoff A, Kluge JG, Gehoff P, Jurisch D, Pfeifer D, Hinz J, et al. Recurrent strokes under anticoagulation therapy: Sticky platelet syndrome combined with a patent foramen ovale. J Cardiovasc Dis Res 2011; 2: 68-70.

  31. Rac MW, Minns Crawford N, Worley KC. Extensive thrombosis and first-trimester pregnancy loss caused by sticky platelet syndrome. Obstet Gynecol 2011; 117: 501-503.

  32. Ruíz-Argüelles GJ, Alarcón-Urdaneta C, Calderón-García J, Ruíz-Delgado GJ. Primary thrombophilia in México. VIII: descrption of five kindreds of familial sticky platelet syndrome phenotype. Rev Hematol Mex 2011; 12: 73-78.

  33. Stasko J, Bartosova L, Mytnik M, Kubisz P. Are the platelets activated in sticky platelet syndrome? Thromb Res 2011; 128: 96-97.

  34. Kotulicova D, Chudy P, Skerenova M, Ivankova J, Dobrotova M, Kubisz P. Variability of GP6 gene in patients with sticky platelet syndrome and deep venous thrombosis and/or pulmonary embolism. Blood Coagul Fibrinolysis 2012; 23: 543-547.

  35. Kubisz P, Ivankova J, Skerenova M, Stasko J, Holly P. The prevalence of the platelet glycoprotein VI polymorphisms in patients with sticky platelet syndrome and ischemic stroke. Hematology 2012; 17: 355-362.

  36. Darulova S, Samos M, Sokol J, Simonova R, Kovar F, Galajda P, et al. Sticky platelets syndrome in a young patient with massive pulmonary embolism. Am J Case Rep 2013; 14: 169-172.

  37. Moncada B, Ruíz-Argüelles GJ, Castillo- Martínez C. The sticky platelet syndrome. Hematology 2013; 18: 230-232.

  38. Ruíz-Argüelles GJ, Garcés-Eisele J, Camacho- Alarcón C, Reyes-Nuñez V, Moncada- González B, Valdes-Tapia P, et al. Primary thrombophilia in México IX: the glycoprotein IIIa PLA1/A2 polymorphism is not associated with the sticky platelet syndrome phenotype. Clin Appl Thromb Hemost 2013; 19: 689-692.

  39. Simonova R, Bartosova L, Chudy P, Stasko J, Rumanova S, Sokol J, et al. Nine kindreds of familial sticky platelet syndrome phenotype. Clin Appl Thromb Hemost 2013; 19: 395-401.

  40. Tekgunduz E, Demir M, Akyol Erikci A, Akpinar S, Ozturk E, Kirkizlar O. Sticky platelet syndrome in patients with uninduced venous thrombosis. Turk J Haematol 2013; 30: 48-52.

  41. Velázquez-Sánchez-de-Cima S, Zamora-Ortiz G, Hernández-Reyes J, Vargas-Espinosa J, García-Chavez J, Rosales-Padrón J, et al. Primary thrombophilia in Mexico X: A Prospective study of the treatment of the sticky platelet syndrome. Clin Appl Thromb Hemost 2013.

  42. Kubisz P. Response to “Comment on Sticky platelet syndrome”. Semin Thromb Hemost 2014; 40: 274.

  43. Kubisz P, Ruíz-Argüelles GJ, Stasko J, Holly P, Ruíz-Delgado GJ. Sticky platelet syndrome: history and future perspectives. Semin Thromb Hemost 2014; 40: 526-534.

  44. Ruíz-Argüelles GJ. Comment on sticky platelet syndrome. Semin Thromb Hemost 2014; 40: 273.

  45. Beltrán E, Linares P, Castaño S. El síndrome de la plaqueta pegajosa. Primer reporte de casos en niños en Colombia y revisión de la literatura. Pediatría 2002; 37: 15-21.

  46. Ruíz-Argüelles GJ, Ruíz-Delgado GJ, López- Martínez B. El sindrome de las “plaquetas pegajosas”: una causa frecuente pero ignorada de trombofilia. Rev Invest Clin 2002; 54: 394-396.

  47. Velásquez AI, Carmona V, Ramos G. El síndrome de la plaqueta pegajosa. Serie de casos en gestantes en el Hospital Militar Central y revisión de literatura. Rev Colomb Obstret Ginecol 2004; 55: 232-239.

  48. Lazo-Langner A. Síndrome de las plaquetas pegajosas. Rev Invest Clin 2004; 56: 103-104.

  49. Velásquez AII, Carmona V, Ramos G. El síndrome de plaqueta pegajosa: serie de casos en gestantes en el Hospital Militar Central y revisión de literatura. Rev Colomb Obstret Ginecol 2004; 55: 232-239.

  50. Parra-Ortega I, Ruíz-Argüelles GJ. Trombofilia multifactorial en México: descripción del caso en 18 pacientes mestizos mexicanos con el síndrome de las plaquetas pegajosas Med Int Mex 2006; 22: 93-96.

  51. Parra-Ortega I, Estrada-Gómez R, J. R-AG. Síndrome de las plaquetas pegajosas, la condición de trombofilia heredada más frecuente en pacientes mexicanos. Medicina Universitaria 2007; 9 20-23.

  52. Esquivel D, Franco-Pretto EF, Gonzalez G, Correa D. Síndrome de plaquetas pegajosas. reporte de 2 casos en el servicio de Cirugía Oral y Maxilofacial Padiátrica de la Fundación Hospital de la Misericordia. Rev Esp Cir Oral Maxilofac 2014; Nov 20 [Epub ahead of print].

  53. Rodríguez-Pérez LM, Castillo-González D, Tejada-González M, Zamora-González Y, Cabrera-Payne Y, Fonseca-Polanco C. Frecuencia del síndrome de plaquetas pegajosas en pacientes con pérdidas fetales recurrentes. Rev Cub Hematol Inmunol y Hemoter 2014; 30: 374-380.

  54. Colwell JA, Halushka PV, Sarji KE, Sagel J. Platelet function and diabetes mellitus. Med Clin North Am 1978; 62: 753-766.

  55. Paton RC, Passa P. Platelets and diabetic vascular disease. Diabete Metab 1983; 9: 306-312.

  56. Killip T. Unstable angina - an overview. Herz 1980; 5: 72-78.

  57. Remuzzi G, Mecca G, Marchesi D, Livio M, de Gaetano G, Donati MB, et al. Platelet hyperaggregability and the nephrotic syndrome. Thromb Res 1979; 16: 345-354.

  58. Walter E, Deppermann D, Andrassy K, Koderisch J. Platelet hyperaggregability as a consequence of the nephrotic syndrome. Thromb Res 1981; 23: 473-479.

  59. Ahlawat S, Pati HP, Bhatla N, Fatima L, Mittal S. Plasma platelet aggregating factor and platelet aggregation studies in preeclampsia. Acta Obstet Gynecol Scand 1996; 75: 428-431.

  60. Couch JR, Hassanein RS. Platelet aggregability in migraine. Neurology 1977; 27: 843-848.

  61. Lou HC, Nielsen JD, Bomholt A, Gormsen J. Platelet hyperaggregability in young patients with completed stroke. Acta Neurol Scand 1977; 56: 326-334.

  62. Stead RJ, Barradas MA, Mikhailidis DP, Jeremy JY, Hodson ME, Batten JC, et al. Platelet hyperaggregability in cystic fibrosis. Prostaglandins Leukot Med 1987; 26: 91-103.

  63. Leong KC, Tan PL. Central retinal vein thrombosis in a woman on contraceptive pills. Singapore Med J 1974; 15: 156-157.

  64. Ando F, Kato M, Goto S, Kobayashi K, Ichikawa H, Kamiya T. Platelet function in bilateral acute retinal necrosis. Am J Ophthalmol 1983; 96: 27-32.

  65. Luck P, Mikhailidis DP, Dashwood MR, Barradas MA, Sever PS, Dandona P, et al. Platelet hyperaggregability and increased alphaadrenoceptor density in anorexia nervosa. J Clin Endocrinol Metab 1983; 57: 911-914.

  66. Burgess JK, Chong BH. The platelet proaggregating and potentiating effects of unfractionated heparin, low molecular weight heparin and heparinoid in intensive care patients and healthy controls. Eur J Haematol 1997; 58: 279-285.

  67. Froehler MT. Successful treatment of cerebral venous sinus thrombosis with the solitaire FR thrombectomy device. J Neurointerv Surg 2013; 5: e45.

  68. Lahey JM, Kearney JJ, Tunc M. Hypercoagulable states and central retinal vein occlusion. Curr Opin Pulm Med 2003; 9: 385-392.

  69. Alexandra AO, Drenser KA. Hypercoagulable state in a patient with a retinal vein occlusion. Retin Cases Brief Rep 2011; 5: 76-78.

  70. Cellai AP, Lami D, Fedi S, Marcucci R, Mannini L, Cenci C, et al. A hypercoagulable and hypofibrinolytic state is detectable by global methods in patients with retinal vein occlusion. Atherosclerosis 2012; 224: 97-101.

  71. Glueck CJ, Hutchins RK, Jurantee J, Khan Z, Wang P. Thrombophilia and retinal vascular occlusion. Clin Ophthalmol 2012; 6: 1377- 1384.

  72. Abbate R, Boddi M, Prisco D, Gensini GF. Ability of whole blood aggregometer to detect platelet hyperaggregability. Am J Clin Pathol 1989; 91: 159-164.

  73. Abrams J. Medical therapy of unstable angina and non-Q-wave myocardial infarction. Am J Cardiol 2000; 86: 24J-33J.

  74. Jha S, Varma M, Garg R, Kar AM. Platelet aggregation in migraine. J Assoc Physicians India 1992; 40: 153-154.

  75. Crassard I, Conard J, Bousser MG. Migraine and haemostasis. Cephalalgia 2001; 21: 630- 636.

  76. Kutai M, Raviv R, Levin C, Hugeirat Y, Shalev S, Zalman L, et al. Migraine and hypercoagulability, are they related? A clinical study of thrombophilia in children with migraine. Br J Haematol 2011; 152: 349-351.

  77. Lechner H, Ott E, Fazekas F, Pilger E. Evidence of enhanced platelet aggregation and platelet sensitivity in migraine patients. Cephalalgia 1985; 5 (Suppl 2): 89-91.

  78. Fodor M, Facsko A, Berenyi E, Sziklai I, Berta A, Pfliegler G. Transient visual loss triggered by scuba diving in a patient with a petrous epidermoid and combined thrombotic risk factors. Pathophysiol Haemost Thromb 2007; 36: 311-314.

  79. Chaturvedi S, Dzieczkowski J. Multiple hemostatic abnormalities in young adults with activated protein C resistance and cerebral ischemia. J Neurol Sci 1998; 159: 209-212.

  80. Bick RL, Hoppensteadt D. Recurrent miscarriage syndrome and infertility due to blood coagulation protein/platelet defects: a review and update. Clin Appl Thromb Hemost 2005; 11: 1-13.

  81. Ruíz-Argüelles GJ, López-Martínez B, Valdes-Tapia P, Gómez-Rangel JD, Reyes- Nuñez V, Garcés-Eisele J. Primary thrombophilia in México. V. A comprehensive prospective study indicates that most cases are multifactorial. Am J Hematol 2005; 78: 21-26.

  82. Bick RL. Recurrent miscarriage syndrome due to blood coagulation protein/platelet defects: prevalence, treatment and outcome results. DRW Metroplex Recurrent Miscarriage Syndrome Cooperative Group. Clin Appl Thromb Hemost 2000; 6: 115-125.

  83. Undar L, Turkay C, Korkmaz L. Circadian variation in circulating platelet aggregates. Ann Med 1989; 21: 429-433.

  84. Jafri SM, VanRollins M, Ozawa T, Mammen EF, Goldberg AD, Goldstein S. Circadian variation in platelet function in healthy volunteers. Am J Cardiol 1992; 69: 951-954.

  85. Spano GM, La Mancusa R, Pettirossi G, Pulcinelli FM, Gazzaninga PP, Cordova C. Circadian variations in platelet aggregability in non insulin dependent diabetes patients (NIDDM). Clin Ter 1993; 142: 19-22.

  86. Rydzewski A, Malyszko J, Borawski J, Pawlak D, Azzadin A, Buczko W, et al. Altered circadian rhythm of platelet aggregation in hemodialyzed patients. Nephron 1997; 77: 365-367.

  87. Feuring M, Wehling M, Ruf A, Schultz A. Circadian variation of platelet function measured with the PFA-100. Platelets 2009; 20: 466-470.

  88. Bonten TN, Saris A, van Oostrom MJ, Snoep JD, Rosendaal FR, Zwaginga J, et al. Effect of aspirin intake at bedtime versus on awakening on circadian rhythm of platelet reactivity. A randomised cross-over trial. Thromb Haemost 2014; 112: 1209-1218.

  89. Favaloro EJ, Lippi G, Adcock DM. Preanalytical and postanalytical variables: the leading causes of diagnostic error in hemostasis? Semin Thromb Hemost 2008; 34: 612-634.

  90. Wallin O, Soderberg J, Grankvist K, Jonsson PA, Hultdin J. Preanalytical effects of pneumatic tube transport on routine haematology, coagulation parameters, platelet function and global coagulation. Clin Chem Lab Med 2008; 46: 1443-1449.

  91. Bolliger D, Seeberger MD, Tanaka KA, Dell-Kuster S, Gregor M, Zenklusen U, et al. Pre-analytical effects of pneumatic tube transport on impedance platelet aggregometry. Platelets 2009; 20: 458-465.

  92. Hubner U, Bockel-Frohnhofer N, Hummel B, Geisel J. The effect of a pneumatic tube transport system on platelet aggregation using optical aggregometry and the PFA-100. Clinical Laboratory 2010; 56: 59-64.

  93. Kratz A, Salem RO, Van Cott EM. Effects of a pneumatic tube system on routine and novel hematology and coagulation parameters in healthy volunteers. Arch Pathol Lab Med 2007; 131: 293-296.

  94. Franchini M, Mannucci PM. Hypercoagulability in congenital haemolytic anaemias. Blood Transfus 2012; 10: 423-427.

  95. Hayes C, Kitahara S, Tcherniantchouk O. Decreased treshold of aggregation to lowdose epinephrine is evidence of platelet hyperaggregability in patients with thrombosis. Hematol Rep 2014; 6: 5326.

  96. Campuzano-Maya G. PFA-100: una nueva prueba de función plaquetaria sustituta del tiempo de sangría. Medicina & Laboratorio 2013; 19: 411-448.

  97. Lanas A, Fuentes J, Benito R, Serrano P, Bajador E, Sainz R. Helicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low-dose aspirin. Aliment Pharmacol Ther 2002; 16: 779-786.

  98. Giral A, Ozdogan O, Celikel CA, Tozun N, Ulusoy NB, Kalayci C. Effect of Helicobacter pylori eradication on anti-thrombotic dose aspirin-induced gastroduodenal mucosal injury. J Gastroenterol Hepatol 2004; 19: 773- 777.

  99. Malfertheiner P, Megraud F, O’Morain CA, Atherton J, Axon AT, Bazzoli F, et al. Management of Helicobacter pylori infection--the Maastricht IV/Florence Consensus Report. Gut 2012; 61: 646-664.




2020     |     www.medigraphic.com